Literature DB >> 28852344

Total Shoulder Arthroplasty: Is Less Time in the Hospital Better?

Kyle R Duchman1, Chris A Anthony1, Robert W Westermann1, Andrew J Pugely1, Yubo Gao1, Carolyn M Hettrich1.   

Abstract

BACKGROUND: The incidence of total shoulder arthroplasty (TSA) has increased significantly over the last decade. Short-stay protocols for other highvolume procedures have been shown to be safe and effective but have yet to be fully explored for TSA. Our purpose in comparing short-stay and inpatient TSA was to determine: (1) patient demographics and comorbidities, (2) 30-day morbidity, mortality, and readmissions using a matched analysis, and (3) independent predictors of 30-day complications.
METHODS: The American College of Surgeons National Surgical Quality Improvement (ACS NSQIP) database was queried and all patients undergoing elective, primary TSA between 2006 and 2013 were identified. Patients were categorized as short-stay or inpatient based on day of discharge. Propensity score matching was used to adjust for selection bias. Univariate and multivariate statistical analysis was used to compare 30-day morbidity and mortality between the two cohorts.
RESULTS: Overall, 4,619 cases were available, with inpatient admission occurring in 65.7% of patients. Prior to propensity score matching, short-stay patients were significantly younger, more frequently male, with fewer comorbid conditions. After matching, inpatient admission was associated with increased rates of urinary tract infection (1.1% vs. 0.1%; p = 0.001), blood transfusion (5.3% vs. 0.8%; p < 0.001), and total complications (4.7% vs. 1.8%; p < 0.001). Multivariate analysis identified inpatient admission as an independent risk factor for 30-day complication following TSA.
CONCLUSIONS: Short-stay TSA is a safe option for the appropriately selected patient. Inpatient admission was an independent risk factor for complication following TSA. Level of Evidence: III.

Entities:  

Mesh:

Year:  2017        PMID: 28852344      PMCID: PMC5508292     

Source DB:  PubMed          Journal:  Iowa Orthop J        ISSN: 1541-5457


  36 in total

1.  Analysis of transfusion predictors in shoulder arthroplasty.

Authors:  Peter J Millett; Mason Porramatikul; Neal Chen; David Zurakowski; Jon J P Warner
Journal:  J Bone Joint Surg Am       Date:  2006-06       Impact factor: 5.284

2.  Differences in short-term complications between unicompartmental and total knee arthroplasty: a propensity score matched analysis.

Authors:  Kyle R Duchman; Yubo Gao; Andrew J Pugely; Christopher T Martin; John J Callaghan
Journal:  J Bone Joint Surg Am       Date:  2014-08-20       Impact factor: 5.284

3.  Ambulatory continuous interscalene nerve blocks decrease the time to discharge readiness after total shoulder arthroplasty: a randomized, triple-masked, placebo-controlled study.

Authors:  Brian M Ilfeld; Krista Vandenborne; Pamela W Duncan; Daniel I Sessler; F Kayser Enneking; Jonathan J Shuster; Douglas W Theriaque; Terese L Chmielewski; Eugene H Spadoni; Thomas W Wright
Journal:  Anesthesiology       Date:  2006-11       Impact factor: 7.892

4.  Future patient demand for shoulder arthroplasty by younger patients: national projections.

Authors:  Eric M Padegimas; Mitchell Maltenfort; Mark D Lazarus; Matthew L Ramsey; Gerald R Williams; Surena Namdari
Journal:  Clin Orthop Relat Res       Date:  2015-03-11       Impact factor: 4.176

5.  What Are Risk Factors for 30-day Morbidity and Transfusion in Total Shoulder Arthroplasty? A Review of 1922 Cases.

Authors:  Chris A Anthony; Robert W Westermann; Yubo Gao; Andrew J Pugely; Brian R Wolf; Carolyn M Hettrich
Journal:  Clin Orthop Relat Res       Date:  2014-12-19       Impact factor: 4.176

6.  Thirty-Day Morbidity After Single-Level Anterior Cervical Discectomy and Fusion: Identification of Risk Factors and Emphasis on the Safety of Outpatient Procedures.

Authors:  Christopher T Martin; Andrew J Pugely; Yubo Gao; Sergio Mendoza-Lattes
Journal:  J Bone Joint Surg Am       Date:  2014-08-06       Impact factor: 5.284

7.  Predictors of early complications of total shoulder arthroplasty.

Authors:  Peter N Chalmers; Anil K Gupta; Zain Rahman; Benjamin Bruce; Anthony A Romeo; Gregory P Nicholson
Journal:  J Arthroplasty       Date:  2013-08-06       Impact factor: 4.757

8.  Differences in short-term complications between spinal and general anesthesia for primary total knee arthroplasty.

Authors:  Andrew J Pugely; Christopher T Martin; Yubo Gao; Sergio Mendoza-Lattes; John J Callaghan
Journal:  J Bone Joint Surg Am       Date:  2013-02-06       Impact factor: 5.284

9.  Development of a regional model of care for ambulatory total shoulder arthroplasty: a pilot study.

Authors:  S H Gallay; J J A Lobo; J Baker; K Smith; K Patel
Journal:  Clin Orthop Relat Res       Date:  2008-02-10       Impact factor: 4.176

10.  Day of surgery discharge after unicompartmental knee arthroplasty: an effective perioperative pathway.

Authors:  Joseph S Gondusky; Leera Choi; Naila Khalaf; Jay Patel; Steven Barnett; Robert Gorab
Journal:  J Arthroplasty       Date:  2013-10-31       Impact factor: 4.757

View more
  4 in total

1.  Trends in operative duration of total shoulder arthroplasty from 2008 to 2018: a national database study.

Authors:  Edward J Testa; Nicholas J Lemme; Lambert T Li; Steven DeFroda
Journal:  Shoulder Elbow       Date:  2021-04-24

2.  Thirty-day Complications and Readmission Rates in Elderly Patients After Shoulder Arthroplasty.

Authors:  Justin Koh; Joseph W Galvin; David C Sing; Emily J Curry; Xinning Li
Journal:  J Am Acad Orthop Surg Glob Res Rev       Date:  2018-11-02

3.  Delayed hospital discharge after total shoulder arthroplasty: why, and who is at risk?

Authors:  Mariano E Menendez; Sarah M Lawler; Michael P Carducci; David Ring; Kuhan A Mahendraraj; Andrew Jawa
Journal:  JSES Open Access       Date:  2019-09-17

4.  COVID-19 as a Catalyst for Same-Day Discharge Total Shoulder Arthroplasty.

Authors:  Mariano E Menendez; Noah Keegan; Brian C Werner; Patrick J Denard
Journal:  J Clin Med       Date:  2021-12-16       Impact factor: 4.241

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.